TGFB1 and esophageal squamous cell carcinoma: Furthermore, aberrant expression of miR-455-3p in ESCC cells has been reported to activate the Wnt/β-catenin and TGF-β/SMAD signaling pathways through the concurrent suppression of multiple negative regulators of these pathways [167].